Tuomas Kiviniemi is an expert in Cardiology at Turku University Hospital (Finland). As of October 2026, ScienceLeadR ranks Tuomas Kiviniemi in the top 1% of experts worldwide for Atrial Fibrillation. Tuomas Kiviniemi has authored 213 publications, the most recent in 2026, and is an investigator in 22 clinical trials, 3 of them ongoing. SLR score: 859 (community average: 125). How the SLR is computed.

LeadR Profile

Tuomas Kiviniemi Turku University Hospital Finland
859 ScienceLeadR Reputation 859
Network Map

Cardiology

Subspecialties: Neurosurgery - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Turku University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 213

Citations

Citations: 5 809 1st author: 27 Last author: 40 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Composition of Troponin Release After Elective On-Pump and Off-Pump Cardiac Surgery.
PMID 42663617 — heart diseases, myocardial infarction, troponin
J Am Heart Assoc20260
Prophylactic Surgical Left Atrial Appendage Closure in Bioprosthetic Aortic Valve Replacement: Short-Term Outcomes of Randomized Controlled LAA-CLOSURE Trial.
PMID 42622223 — heart diseases, atrial appendage, embolism, hemorrhage, stroke, atrial fibrillation, aortic valve, surgical aortic valve replacement
J Am Heart Assoc20260
Real-world performance of postpericardiotomy syndrome diagnostic criteria-An analysis of the prospective Cardiovascular Research Consortium-A Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients (CAREBANK) database.
PMID 42604360 — mortality, thoracic surgery, pericardium, incidence, biomarkers, postpericardiotomy syndrome, diagnosis, morbidity, research
JTCVS Open20260
European Society of Cardiology: cardiovascular disease statistics 2025.
PMID 42150766 — cardiovascular diseases, income, risk management, cardiology
Eur Heart J Top journal20260
Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement.
PMID 42112509 — hemorrhage, stroke, incidence, aspirin, aortic valve, therapeutics, surgical aortic valve replacement
Int J Cardiol Heart Vasc20260

Clinical Studies 22

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 1 Study Director: 2

By phase:

N/A 19
Phase 3 3

By status:

Completed 12
Active not recruiting 4
Recruiting 3
Unknown 2
Terminated 1

By type:

Observational 14
Interventional 8

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 6
multicentric5to9 1
multicentricup10 5

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High Bad Cholesterol from an Inherited Condition
2025-520520-17-00 — cholesterol, ldl, lipoproteins, cholesterol, lipoproteins, ldl
Phase 3Active not recruiting2025
Low Workload Concept for the Detection of Silent Atrial Fibrillation (AF) and Atrial Fibrillation Burden in Patients at High Risk of AF and Stroke
NCT05351775 — mortality, heart diseases, hospitalization, stroke, heart, arrhythmias, cardiac, data collection, cardiovascular diseases, workload, atrial fibrillation, algorithms, cardiology, photoplethysmography, smartphone, mobile applications, diagnosis, research, beds, therapeutics, pathologic processes, electrocardiography, postoperative complications
N/AActive not recruiting2022
Drug Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI
NCT04814212 — myocardial ischemia, stents, hemorrhage, drug-eluting stents, coronary artery disease, pharmaceutical preparations, percutaneous coronary intervention, acute coronary syndrome, arteries, coronary disease, ischemia
N/ARecruiting2022

LeadR Networks

Main global connection map